{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:38:51Z","timestamp":1778834331611,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,9,1]],"date-time":"1995-09-01T00:00:00Z","timestamp":809913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1007\/bf00873802","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T20:03:48Z","timestamp":1105128228000},"page":"211-215","source":"Crossref","is-referenced-by-count":9,"title":["A Phase I study of acivicin in refractory pediatric solid tumors"],"prefix":"10.1007","volume":"13","author":[{"given":"Sylvain","family":"Baruchel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Michael","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Dubowy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holcombe","family":"Grier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Kretschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Langevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Vietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00873802_CR1","first-page":"793","volume":"58","author":"DA Cooney","year":"1974","unstructured":"Cooney DA, Jayaram HN, Ryan JA, Bono VH: Inhibition of L-asparagine synthetase by a new amino acid antibiotic with antitumor activity: L-(\u03b15,5S)-\u03b1-ami-no-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501). Cancer Chemother Rep 58:793\u2013802, 1974","journal-title":"Cancer Chemother Rep"},{"key":"BF00873802_CR2","first-page":"484","volume-title":"Handbook of Experimental Pharmacology, Vol. 38, No. 2","author":"LL Bennett Jr.","year":"1975","unstructured":"Bennett LL Jr. Glutamine antagonist. In: Sartorelli AC, Johns DG (eds) Handbook of Experimental Pharmacology, Vol. 38, No. 2. Springer-Verlag, New York, 1975, pp. 484\u2013511"},{"key":"BF00873802_CR3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0006-291X(80)90557-4","volume":"94","author":"DJ Reed","year":"1980","unstructured":"Reed DJ, Ellis WW, Meck RA: The inhibition of gamma-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells L-(\u03b1, 5S)-\u03b1-ammo-3-chlo-ro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501). Biochem Biophys Res Commun 94:1273\u20131277, 1980","journal-title":"Biochem Biophys Res Commun"},{"key":"BF00873802_CR4","first-page":"420","volume":"27","author":"N Prajda","year":"1986","unstructured":"Prajda N: Biochemical mechanism of action of acivicin in rat bone marrow. Proc Am Assoc Cancer Res 27:420, 1986","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00873802_CR5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1200\/JCO.1984.2.9.1064","volume":"2","author":"PJ O'Dwyer","year":"1984","unstructured":"O'Dwyer PJ, Alonso MT, Leyland-Jones B: Acivicin: a new glutamine antagonist in clinical trials. J Clin Oncol 2:1064\u20131071, 1984","journal-title":"J Clin Oncol"},{"key":"BF00873802_CR6","unstructured":"National Cancer Institute, Division of Cancer Treatment. Clinical brochure: Acivicin AT 125, p. 13, Aug., 1984"},{"key":"BF00873802_CR7","first-page":"4077","volume":"45","author":"G Dranoff","year":"1985","unstructured":"Dranoff G, Elion GB, Friedman HS, Bigner DD: Influence of glutamine on the growth of human glioma and medulloblastoma in culture. Cancer Res 45:4077\u20134081, 1985","journal-title":"Cancer Res"},{"key":"BF00873802_CR8","first-page":"473","volume":"63","author":"DP Houchens","year":"1979","unstructured":"Houchens DP, Ovejera AA, Sheridan MA, Johnson RK, Boden AE, Neil GL: Therapy for mouse tumors and human tumor xenografts with the antitumor antibiotic AT-125. Cancer Treat Rep 63:473\u2013476, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00873802_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4899-2638-8_5","volume":"309A","author":"RC Trueworthy","year":"1991","unstructured":"Trueworthy RC, DeAbreu RA, Lambooy LH, Bokkerink JP, Stet EH: Action and sequence dependent interaction of acivicin and 6-thioguanine in human derived malignant T-ALL and CALLA+ cell lines. Adv Exp Med Biol 309A:25\u201328, 1991","journal-title":"Adv Exp Med Biol"},{"issue":"l","key":"BF00873802_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-291X(89)91555-6","volume":"161","author":"H Futami","year":"1989","unstructured":"Futami H, Shiotani T, Yamaji Y, Yamauchi N, Irino S: Effect of cisplatinum and acivicin on pyrimidine metabolism in A-549 human lung cancer cells. Biochem Biophys Res Comm 161(l):31\u201333, 1989","journal-title":"Biochem Biophys Res Comm"},{"key":"BF00873802_CR11","first-page":"414A","volume":"30","author":"K Bhalla","year":"1982","unstructured":"Bhalla K, Nayak R, Deitch A, Grant S: Antitumor synergism between acivicin (AT-125) and 6-thioguanine in the murine leukemia L1210. Clin Res 30:414A, 1982","journal-title":"Clin Res"},{"key":"BF00873802_CR12","first-page":"362","volume":"22","author":"RJ Belt","year":"1981","unstructured":"Belt RJ, Taylor SA, Haas CD, Joseph Y, Hoogstraten B: Phase I trial of AT-125 (Acivicin, NSC 163501). Proc Am Soc Clin Oncol 22:362, 1981","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00873802_CR13","first-page":"3892","volume":"42","author":"GR Weiss","year":"1982","unstructured":"Weiss GR, McGovren JP, Schade D, Kufe DW: Phase I and pharmacological study of acivicin by 24-hour continuous infusion. Cancer Res 42:3892\u20133895, 1982","journal-title":"Cancer Res"},{"key":"BF00873802_CR14","first-page":"683","volume":"67","author":"RH Earhart","year":"1983","unstructured":"Earhart RH, Koeller JM, Davis TE, Borden EC, McGovren JP, Davis HL, Tormey DC: Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion. Cancer Treat Rep 67:683\u2013692, 1983","journal-title":"Cancer Treat Rep"},{"key":"BF00873802_CR15","first-page":"23","volume":"23","author":"WK Murphy","year":"1982","unstructured":"Murphy WK, Burgess MA, Valdevieso M, Bodey GP: Phase I evaluation of acivicin (AT 125). Proc Am Soc Clin Oncol 23:23, 1982","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00873802_CR16","first-page":"701","volume":"67","author":"KS Sridhar","year":"1983","unstructured":"Sridhar KS, Ohnuma T, Chahinian AP, Holland JF: Phase I study of acivicin in patients with advanced cancer. Cancer Treat Rep 67:701\u2013703, 1983","journal-title":"Cancer Treat Rep"},{"key":"BF00873802_CR17","first-page":"4460","volume":"45","author":"JP McGovren","year":"1985","unstructured":"McGovren JP, Pratt EA, Belt RJ, Taylor SA: Pharmacokinetic and biochemical studies on acivicin in Phase I clinical trials. Cancer Res 45:4460\u20134463, 1985","journal-title":"Cancer Res"},{"issue":"8","key":"BF00873802_CR18","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.1991.9.8.1476","volume":"9","author":"SA Taylor","year":"1991","unstructured":"Taylor SA, Crowley J, Pollock TW, Eyre HJ, Jaeckle C, Hynes HE, Stephens RE: Objective antitumor activity in patients with recurrent CNS malignancies: a South West Oncology Group trial. J Clin Oncol 9(8): 1476\u20131479, 1991","journal-title":"J Clin Oncol"},{"key":"BF00873802_CR19","first-page":"843","volume":"67","author":"G Fleischman","year":"1983","unstructured":"Fleischman G, Yap HY, Murphy WK, Bodey GP: Phase II trial of acivicin in advanced metastatic breast cancer. Cancer Treat Rep 67:843\u2013844, 1983","journal-title":"Cancer Treat Rep"},{"key":"BF00873802_CR20","first-page":"1333","volume":"66","author":"JP McGovren","year":"1982","unstructured":"McGovren JP, Stewart JC, Elfring GL, Smith RB, Scares N, Wood JH, Poplack DG, Von Hoff DD: Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. Cancer Treat Rep 66:1333\u20131341, 1982","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"BF00873802_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00176821","volume":"3","author":"KE Hill","year":"1985","unstructured":"Hill KE, Von Hoff DD, Burk RF: Effect of inhibition of gamma-glutamyltranspeptidase by AT-125 (Acivicin) on glutathione and cysteine level in rat brain and plasma. Invest New Drugs 3(1):31\u201334, 1985","journal-title":"Invest New Drugs"},{"key":"BF00873802_CR22","first-page":"A427","volume":"12","author":"S Field","year":"1993","unstructured":"Field S, Rodriguez G, Burris H, Eckardt J, Smith L, Weiss G, Smith S, Kuhn J, Von Hoff D: Concomittant administration of acivicin and aminosyn by continuous infusion. Proc Am Soc Clin Oncol 12:A427, 1993","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"l","key":"BF00873802_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00121327","volume":"7","author":"MJ Meredith","year":"1991","unstructured":"Meredith MJ: Glutathione and glutathione conjugate efflux from cultured liver cells. Cell Biology & Tox 7(l):15\u201333, 1991","journal-title":"Cell Biology & Tox"},{"issue":"5","key":"BF00873802_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000421-199010000-00007","volume":"13","author":"JA Maroun","year":"1990","unstructured":"Maroun JA, Stewart DJ, Erma S, Evans WK, Eisenhauer E: Phase I study of acivicin and cisplatin in non-small-cell lung cancer. A National Cancer Institute of Canada Study. Am J Clin Oncol 13(5): 401\u2013404, 1990","journal-title":"Am J Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00873802\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00873802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:46:18Z","timestamp":1678556778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00873802"}},"subtitle":["A Pediatric Oncology Group study"],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["BF00873802"],"URL":"https:\/\/doi.org\/10.1007\/bf00873802","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}